A

Alkermes plc
D

ALKS

31.785
USD
1.23
(4.01%)
مغلق
حجم التداول
124,318
الربح لكل سهم
2
العائد الربحي
-
P/E
14
حجم السوق
5,239,319,475
أصول ذات صلة
A
ACAD
0.355
(2.44%)
14.905 USD
A
ALK
2.580
(5.81%)
46.970 USD
A
ALX
4.790
(2.28%)
214.810 USD
E
EBS
0.22000
(4.48%)
5.13000 USD
INCY
INCY
0.500
(0.81%)
62.500 USD
المزيد
الأخبار المقالات

العنوان: Alkermes plc

القطاع: Healthcare
الصناعة: Drug Manufacturers - Specialty & Generic
Alkermes PLC is a fully integrated biotechnology company that applies its proprietary technologies to research, develop, and commercialize pharmaceutical products designed for unmet medical needs in therapeutic areas. The company utilizes several to develop and commercialize products and, in so doing, access technological, financial, marketing, manufacturing, and other resources. Alkermes either purchases active drug products from third parties or receives them from its third-party licensees to formulate products using its technologies. It operates in U.S., which derives maximum revenue, Ireland and Rest of the world.